AstraZeneca PLC (AZN)

AstraZeneca PLC researches, develops, manufactures, and markets biopharmaceuticals and vaccines focused on oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology. Notable products include Tagrisso for certain lung cancers, Farxiga for heart failure and chronic kidney disease, and the COVID-19 vaccine developed in partnership with the University of Oxford. It serves patients and healthcare systems worldwide through prescription medicines and clinical development programs.

Market

Stockholm

Sector

Healthcare

Trend

Strong downtrend

Last close

1,555.5 (-0.96% on the day)

MA50

1,625.33

MA200

1,718.13

52-week range

1,390.11–1,902.02

Market cap

2.4T SEK

P/E

24.31

Dividend yield

0.21%

Data as of

2026-09-04

All markets — KeepWinning global stock screener

Other companies on Stockholm: ABB Ltd (ABB), Investor AB (publ) (INVE A), Atlas Copco AB (publ) (ATCO A), Atlas Copco AB (publ) (ATCO B), AB Volvo (publ) (VOLV B), Nordea Bank Abp (NDA SE)